Dr. Kruse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-444-6386Fax+1 216-444-9464- Is this information wrong?
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2014 - 2017
UPMC Medical EducationResidency, Internal Medicine, 2011 - 2014
Case Western Reserve University School of MedicineClass of 2011
Certifications & Licensure
OH State Medical License 2014 - 2024
PA State Medical License 2011 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) Start of enrollment: 2024 Apr 01
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- Progress in immune checkpoint inhibition in early-stage triple-negative breast cancer.Ahmed Mohamed, Megan Kruse, Jennifer Tran> ;Expert Review of Anticancer Therapy. 2023 Oct 26
- Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real world.Megan Kruse, Emily Nash Smyth, Lee Bowman, Santosh Gautam, Claudia M Guimaraes, Alnecia R Nisbett, Maxine D Fisher, Zhanglin Lin Cui, Kristin M Sheffield, Kevin Kalinsky> ;Breast Cancer Research and Treatment. 2023 Aug 1
- 4 citationsBioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.Chirag Shah, Pat Whitworth, Stephanie Valente, Graham S Schwarz, Megan Kruse, Manpreet Kohli, Kirstyn Brownson, Laura Lawson, Beth Dupree, Frank A Vicini> ;Breast Cancer Research and Treatment. 2023 Feb 1
- Join now to see all
Press Mentions
Cleveland Clinic: First Patient To Receive Breast Cancer Vaccine Shares Health JourneyApril 17th, 2023- First Breast Cancer Vaccine Trial Participant Shares Experience PKGApril 13th, 2023
- Invasive Lobular Carcinoma a Distinctive, Understudied Breast Cancer SubtypeJanuary 5th, 2023
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Cleveland ClinicCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
